Table 2.
QTL name, linkage group (LG), interval, mode peak (Mode), posterior intensity (QTL intensity), phenotypic variance explained (PVE), and Bayes factor (BF) for black spot disease (BSD) evaluated in Texas on six diploid rose populations (TX2WSE) across multiple months and overall mean in 2018 and 2020 Somerville (SV) and 2019 in Overton (OV)
| QTL name | Month | Year | LG | Mode | Interval | QTL | PVE | BFa | |
|---|---|---|---|---|---|---|---|---|---|
| (cM) | (cM) | (%) | |||||||
| qBSD.TX2WSE-LG1.1 | June | 2020 | 1 | 30 | 28.73 | 22.65 | 1.10 | 11 | 6.3 |
| 32.63 | 26.03 | ||||||||
| qBSD.TX2WSE-LG1.2 | June | 2020 | 1 | 54 | 52.16 | 46.54 | 0.50 | 8 | 2.0 |
| 55.52 | 48.46 | ||||||||
| Mean | 2020 | 1 | 54 | 48.36 | 43.80 | 0.85 | 6 | 2.1 | |
| 54.51 | 49.27 | ||||||||
| qBSD.TX2WSE-LG2.1 | Sep. | 2018 | 2 | 100 | 97.39 | 67.73 | 0.72 | 7 | 4.7 |
| 102.35 | 69.76 | ||||||||
| qBSD.TX2WSE-LG2.2 | Mean | 2018 | 2 | 114 | 113.12 | 70.87 | 0.81 | 8 | 3.3 |
| 118.89 | 73.56 | ||||||||
| qBSD.TX2WSE-LG2.3 | Oct. | 2018 | 2 | 137 | 129.77 | 74.57 | 1.10 | 7 | 6.0 |
| 138.68 | 74.95 | ||||||||
| qBSD.TX2WSE-LG3.1 | May | 2020 | 3 | 10 | 0.00 | 15.44 | 1.00 | 9 | 5.3 |
| 18.39 | 27.80 | ||||||||
| Mean | 2019 | 3 | 16 | 12.11 | 16.81 | 1.11 | 33 | 27.8 | |
| 18.39 | 27.80 | ||||||||
| June | 2020 | 3 | 18 | 16.31 | 21.51 | 0.40 | 8 | 3.3 | |
| 18.39 | 27.80 | ||||||||
| Sep. | 2019 | 3 | 18 | 16.31 | 21.51 | 1.03 | 19 | 6.6 | |
| 18.39 | 27.80 | ||||||||
| May | 2018 | 3 | 18 | 17.21 | 22.90 | 1.19 | 24 | 24.9 | |
| 18.39 | 27.80 | ||||||||
| Mean | 2018 | 3 | 18 | 16.31 | 21.51 | 0.72 | 15 | 27.9 | |
| 18.39 | 27.80 | ||||||||
| Mean | 2020 | 3 | 18 | 16.31 | 21.51 | 1.12 | 21 | 27.7 | |
| 18.39 | 27.80 | ||||||||
| June | 2019 | 3 | 18 | 17.21 | 22.90 | 1.09 | 26 | 27.8 | |
| 18.39 | 27.80 | ||||||||
| Oct. | 2018 | 3 | 18 | 5.61 | 11.11 | 0.86 | 6 | 3.8 | |
| 18.39 | 27.80 | ||||||||
| qBSD.TX2WSE-LG3.2 | Sep. | 2018 | 3 | 29 | 25.38 | 30.15 | 0.65 | 19 | 4.5 |
| 29.88 | 29.08 | ||||||||
| qBSD.TX2WSE-LG3.3 | July | 2020 | 3 | 34 | 33.53 | 33.83 | 1.20 | 8 | 27.2 |
| 38.71 | 34.04 | ||||||||
| qBSD.TX2WSE-LG3.4 | May | 2018 | 3 | 50 | 46.19 | 36.72 | 0.55 | 7 | 24.9 |
| 50.49 | 37.81 | ||||||||
| qBSD.TX2WSE-LG4.1 | Nov. | 2018 | 4 | 25 | 22.14 | 11.80 | 0.91 | 13 | 25.7 |
| 27.27 | 20.23 | ||||||||
| June | 2019 | 4 | 26 | 24.47 | 12.90 | 0.44 | 9 | 9.3 | |
| 27.27 | 20.23 | ||||||||
| Mean | 2018 | 4 | 24 | 22.14 | 11.80 | 0.66 | 7 | 26.1 | |
| 27.27 | 20.23 | ||||||||
| qBSD.TX2WSE-LG4.2 | Oct. | 2018 | 4 | 32 | 32.55 | 25.00 | 0.44 | 6 | 2.3 |
| 35.07 | 36.64 | ||||||||
| Sep. | 2018 | 4 | 39 | 32.55 | 25.00 | 0.51 | 8 | 8.1 | |
| 42.29 | 40.32 | ||||||||
| qBSD.TX2WSE-LG5.1 | June | 2019 | 5 | 62 | 60.51 | 20.93 | 0.89 | 9 | 8.6 |
| 62.93 | 24.55 | ||||||||
| July | 2020 | 5 | 66 | 61.01 | 20.44 | 1.14 | 6 | 8.6 | |
| 66.26 | 24.82 | ||||||||
| qBSD.TX2WSE-LG5.2 | Nov. | 2018 | 5 | 78 | 74.36 | 35.12 | 0.80 | 11 | 26.2 |
| 83.82 | 55.02 | ||||||||
| May | 2020 | 5 | 81 | 78.11 | 44.17 | 1.03 | 9 | 8.1 | |
| 83.82 | 55.02 | ||||||||
| Mean | 2018 | 5 | 78 | 77.68 | 43.64 | 0.88 | 12 | 27.4 | |
| 88.70 | 63.28 | ||||||||
| qBSD.TX2WSE-LG5.3 | Oct. | 2018 | 5 | 91 | 90.03 | 63.80 | 1.00 | 26 | 27.3 |
| 93.50 | 63.80 | ||||||||
| qBSD.TX2WSE-LG6 | May | 2020 | 6 | 38 | 35.24 | 28.56 | 1.13 | 15 | 27.1 |
| 39.98 | 39.63 | ||||||||
a
Bayes Factor (2lnBF), a measure quantifies the support from the data for the number of QTL(s) in the model (QTL evidence), after pair-wise model comparison (e.g. 1/0, 2/1, and 3/2) such as “one-QTL model” vs. ‘zero-QTL model, etc. BF ≥ 2, 5, 10 indicating positive, strong, or decisive evidence for the presence of a QTL, respectively.